IMMUNOPOTENTIATOR ENHANCED SUPERANTIGEN MEDIATED CANCER IMMUNOTHERAPY

Title:

IMMUNOPOTENTIATOR ENHANCED SUPERANTIGEN MEDIATED CANCER IMMUNOTHERAPY

Document Type and Number:

WIPO Patent Application WO/2017/122098

Kind Code:

A9

Abstract:

The invention provides methods or compositions for enhancing the potency of a targeted cancer immunotherapy in a subject by using a superantigen in combination with an immunopotentiator (for example, a PD-1 inhibitor).

Inventors:

NATHAN ASHER (IL)
SHAHAR MICHAL (IL)

Application Number:

PCT/IB2017/000511

Publication Date:

December 07, 2017

Filing Date:

January 10, 2017

Export Citation:

Click for automatic bibliography generation Help

Assignee:

NEOTX THERAPEUTICS LTD (IL)

International Classes:

C07K16/28; A61K39/085; A61K39/395

Attorney, Agent or Firm:

REINHOLD COHN & PARTNERS et al. (IL)

Download PDF:

View/Download PDF PDF Help

Previous Patent: HIGHLY AUTOMATED SYSTEM AND METHOD OF USING THE SAME TO MEASURE, MONITOR MANAGE AND CONTROL GRAZING ...

Next Patent: LASER-BASED DEVICE UTILIZING MULTIPLE LASER BEAMS